drugset / Trial / NCT05816070

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

NCT05816070

Phase 2 Completed 129 enrolled IVIEW Therapeutics Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

A Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis

Timeline

Start
2023-01-05
Primary completion
2023-11-13
Completion
2024-10-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ofloxacin Small molecule Other
Subject Povidone-Iodine Other / unclassified 1 % Other